0,882  0,004  Caspase 9 stimulant
0,821  0,014  Apoptosis agonist
0,778  0,018  Antiinflammatory
0,728  0,007  Sensitization
0,725  0,015  Antineoplastic (lung cancer)
0,722  0,017  Antineoplastic (breast cancer)
0,704  0,020  Transcription factor NF kappa B inhibitor
0,694  0,014  Antileukemic
0,692  0,014  TNF expression inhibitor
0,659  0,011  Chemopreventive
0,653  0,018  Antineoplastic (colorectal cancer)
0,649  0,018  Antineoplastic (colon cancer)
0,635  0,005  UGT1A4 substrate
0,629  0,010  UGT1A9 substrate
0,624  0,015  Antihypercholesterolemic
0,584  0,011  Nitric oxide antagonist
0,587  0,014  Antineoplastic (cervical cancer)
0,581  0,013  Hepatic disorders treatment
0,570  0,007  UGT1A1 substrate
0,575  0,014  Antineoplastic (pancreatic cancer)
0,575  0,022  Cholesterol antagonist
0,555  0,003  Neurotrophic factor enhancer
0,571  0,021  Prostate cancer treatment
0,545  0,005  UGT1A3 substrate
0,550  0,021  Antineoplastic (ovarian cancer)
0,546  0,017  12-Lipoxygenase inhibitor
0,539  0,019  Antineoplastic (melanoma)
0,535  0,020  Cytotoxic
0,527  0,025  Antipruritic, allergic
0,501  0,006  Interferon gamma antagonist
0,495  0,005  UGT2B7 substrate
0,495  0,012  UGT2B4 substrate
0,509  0,026  CYP2C19 substrate
0,486  0,004  UGT2B15 substrate
0,492  0,021  Antioxidant
0,491  0,022  Caspase 3 stimulant
0,488  0,020  Antineoplastic (glioma)
0,487  0,020  Cardiovascular analeptic
0,495  0,029  Respiratory analeptic
0,486  0,024  Chemoprotective
0,480  0,023  AR expression inhibitor
0,465  0,022  NOS2 expression inhibitor
0,451  0,015  Antineoplastic (liver cancer)
0,444  0,010  Hepatoprotectant
0,446  0,016  Vascular (periferal) disease treatment
0,432  0,004  UGT2B9 substrate
0,453  0,028  Lipoprotein disorders treatment
0,442  0,024  Proliferative diseases treatment
0,431  0,017  Antineoplastic (endocrine cancer)
0,434  0,022  Tumour necrosis factor alpha release inhibitor
0,415  0,009  Antipruritic, non-allergic
0,437  0,031  Cardioprotectant
0,423  0,018  UDP-glucuronosyltransferase substrate
0,431  0,027  Antineoplastic (non-small cell lung cancer)
0,442  0,052  CYP3A4 substrate
0,419  0,034  NOS3 expression inhibitor
0,408  0,023  UGT1A6 substrate
0,434  0,052  CYP2C9 substrate
0,433  0,052  Immunosuppressant
0,383  0,005  Cholesterol synthesis inhibitor
0,399  0,025  Hypolipemic
0,402  0,029  Hypoxia-inducible factor 1 alpha inhibitor
0,389  0,018  Anesthetic general
0,416  0,045  Bone diseases treatment
0,389  0,021  Antineoplastic (lymphocytic leukemia)
0,392  0,030  DNA damaging
0,380  0,018  Antineoplastic (sarcoma)
0,426  0,066  Antibacterial
0,392  0,033  Antineoplastic (multiple myeloma)
0,370  0,013  Prostate disorders treatment
0,396  0,039  Analeptic
0,387  0,030  Antineoplastic (glioblastoma multiforme)
0,401  0,045  Antifungal
0,394  0,041  Antineoplastic (brain cancer)
0,380  0,027  Antiparasitic
0,377  0,025  Sodium/bile acid cotransporter inhibitor
0,380  0,030  Antihypoxic
0,416  0,068  15-Lipoxygenase inhibitor
0,381  0,033  Calcium channel activator
0,406  0,060  CYP2C19 inhibitor
0,358  0,015  Melanin inhibitor
0,356  0,016  Prostatic (benign) hyperplasia treatment
0,358  0,018  Contraceptive
0,342  0,017  Antiacne
0,371  0,047  Apoptosis antagonist
0,323  0,004  Antiviral (SARS coronavirus)
0,323  0,004  Antiviral (Coronavirus)
0,326  0,007  Heat shock protein 90 antagonist
0,362  0,047  Lipoxygenase inhibitor
0,324  0,014  Antiviral (Influenza A)
0,347  0,040  Antineoplastic (osteosarcoma)
0,335  0,028  Abortion inducer
0,386  0,083  Histamine release inhibitor
0,343  0,040  Free radical scavenger
0,326  0,024  Antiviral (Influenza)
0,309  0,009  Antifungal enhancer
0,316  0,025  Non-steroidal antiinflammatory agent
0,341  0,052  Antiosteoporotic
0,316  0,033  Antineoplastic enhancer
0,302  0,020  Hair growth stimulant
0,325  0,048  Antipyretic
0,280  0,007  Contraceptive female
0,317  0,046  Antineoplastic (lymphoma)
0,281  0,013  Interleukin 1 antagonist
0,288  0,021  Protein-tyrosine phosphatase inhibitor
0,274  0,008  UGT2B10 substrate
0,298  0,035  Platelet adhesion inhibitor
0,310  0,048  Antineoplastic (renal cancer)
0,310  0,051  Antiprotozoal (Leishmania)
0,289  0,034  Antihelmintic
0,335  0,080  Antiprotozoal (Plasmodium)
0,311  0,064  CYP1A2 substrate
0,270  0,025  Anesthetic
0,315  0,080  ICAM1 expression inhibitor
0,332  0,102  Antiprotozoal
0,234  0,005  CDC25A inhibitor
0,239  0,011  SULT1A1 substrate
0,236  0,010  Antiinfertility, female
0,237  0,014  Farnesoid X receptor antagonist
0,245  0,022  NADPH oxidase inhibitor
0,254  0,032  Lipocortins synthesis antagonist
0,261  0,041  Growth hormone agonist
0,229  0,012  UGT2B1 substrate
0,256  0,039  P-glycoprotein inhibitor
0,224  0,015  Arachidonic acid antagonist
0,274  0,067  Transcription factor STAT3 inhibitor
0,222  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,230  0,031  LDLR expression enhancer
0,228  0,032  Lipid peroxidase inhibitor
0,228  0,033  Antiseptic
0,306  0,111  CYP2C9 inhibitor
0,231  0,037  Diabetic nephropathy treatment
0,227  0,033  Protein kinase stimulant
0,224  0,030  Interleukin 6 antagonist
0,208  0,015  Choleretic
0,223  0,032  Skin whitener
0,246  0,058  Antihypertriglyceridemic
0,198  0,011  TRPA1 agonist
0,236  0,049  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,337  0,151  Antineoplastic (solid tumors)
0,241  0,055  RNA-directed DNA polymerase inhibitor
0,217  0,040  Heat shock protein 90 alpha antagonist
0,178  0,002  Heme oxygenase stimulant
0,179  0,005  Glutamate release inhibitor
0,281  0,107  Vasodilator, peripheral
0,188  0,015  HDL-cholesterol increasing
0,179  0,006  Purinergic P2X2 antagonist
0,238  0,066  Interleukin antagonist
0,211  0,042  Liver fibrosis treatment
0,253  0,084  Transcription factor STAT inhibitor
0,242  0,074  Angiogenesis stimulant
0,187  0,019  Sulfotransferase substrate
0,177  0,010  Aromatase inhibitor
0,182  0,016  Androgen antagonist
0,233  0,067  Antimitotic
0,175  0,013  ABCA1 expression enhancer
0,199  0,037  Tubulin antagonist
0,209  0,047  Antineoplastic (gastric cancer)
0,166  0,010  UGT2B11 substrate
0,180  0,024  Antineoplastic antibiotic
0,164  0,008  Ornithine decarboxylase inhibitor
0,236  0,080  Teratogen
0,201  0,046  Antiviral (Herpes)
0,195  0,043  Antineoplastic (squamous cell carcinoma)
0,177  0,028  Adenylate cyclase stimulant
0,200  0,054  Antimutagenic
0,174  0,031  Antihemorrhagic
0,222  0,080  Cardiodepressant
0,174  0,034  Antieczematic
0,247  0,106  Antipsoriatic
0,155  0,015  Anabolic
0,261  0,124  Vasodilator, coronary
0,143  0,007  SULT1A2 substrate
0,137  0,006  Acetyl-CoA transferase inhibitor
0,171  0,040  Monophenol monooxygenase inhibitor
0,215  0,085  Embryotoxic
0,175  0,045  Hemostatic
0,150  0,021  Actinic keratosis treatment
0,173  0,045  SULT1A3 substrate
0,167  0,039  Antihyperlipoproteinemic
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,247  0,121  Interleukin 2 agonist
0,194  0,072  Carcinogenic
0,180  0,061  Antineoplastic (bone cancer)
0,204  0,086  Antiulcerative
0,137  0,019  Inducible nitric-oxide synthase inhibitor
0,152  0,036  Vanilloid 1 agonist
0,226  0,110  Gastrin inhibitor
0,240  0,125  CYP3A4 inhibitor
0,117  0,003  Geranyltranstransferase inhibitor
0,151  0,039  Interleukin 1b antagonist
0,130  0,019  Keratolytic
0,117  0,009  5-Alpha-reductase inhibitor
0,118  0,011  Anticholelithogenic
0,123  0,017  Bile acid receptor antagonist
0,152  0,050  Pregnane X receptor agonist
0,120  0,018  Lipase inhibitor
0,212  0,110  Spasmolytic
0,115  0,014  Glycine receptor agonist
0,112  0,013  CDC25B inhibitor
0,139  0,044  Microtubule formation inhibitor
0,114  0,023  3C-Like protease (SARS coronavirus) inhibitor
0,113  0,022  Vanilloid agonist
0,129  0,039  Estrogen antagonist
0,275  0,185  Cyclophilin D inhibitor
0,275  0,185  Antidiabetic
0,141  0,051  Antiviral (Hepatitis B)
0,216  0,129  CYP2D6 substrate
0,107  0,021  Potassium channel large-conductance Ca-activated activator
0,153  0,068  Antidiarrheal
0,198  0,114  Hypoglycemic
0,139  0,056  DNA polymerase I inhibitor
0,117  0,035  Estrogen receptor beta antagonist
0,112  0,030  Transcription factor NF kappa B stimulant
0,222  0,141  CTGF expression inhibitor
0,139  0,059  Retinoprotector
0,186  0,106  VCAM1 expression inhibitor
0,161  0,082  Catenin beta inhibitor
0,082  0,004  Cholesterol ester transfer protein antagonist
0,163  0,085  Toxic, respiratory center
0,215  0,137  Antimycobacterial
0,083  0,006  Cholesterol esterase inhibitor
0,084  0,007  Retinoid X alpha receptor agonist
0,091  0,014  Heat shock protein 90 beta antagonist
0,098  0,023  HIV-1 integrase (Strand Transfer) inhibitor
0,201  0,127  Antituberculosic
0,093  0,019  Estrogen agonist
0,132  0,058  Alkylator
0,190  0,117  Myocardial infarction treatment
0,155  0,083  Mutagenic
0,105  0,034  Tocolytic
0,153  0,083  Antihelmintic (Nematodes)
0,078  0,008  Retinoid X receptor agonist
0,156  0,088  Dual specificity phosphatase inhibitor
0,109  0,041  Interleukin 12 antagonist
0,128  0,061  Adenylate cyclase inhibitor
0,128  0,060  Growth stimulant
0,132  0,064  CC chemokine 6 receptor antagonist
0,076  0,009  RNA-directed RNA polymerase stimulant
0,096  0,030  Estrogen receptor alpha antagonist
0,199  0,133  Antineoplastic (bladder cancer)
0,141  0,075  Antineoplastic (carcinoma)
0,080  0,016  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,123  0,060  Alcohol dehydrogenase substrate
0,077  0,014  Estradiol 17 beta-dehydrogenase inhibitor
0,115  0,054  Expectorant
0,075  0,017  Postcoital contraceptive
0,072  0,015  Potassium channel Kv1.3 blocker
0,105  0,051  Potassium channel (Ca-activated) activator
0,069  0,016  Pregnane X receptor antagonist
0,177  0,125  Vasodilator
0,096  0,043  Contraceptive male
0,070  0,018  Acetyl-CoA transferase 2 inhibitor
0,060  0,008  Alpha 1L adrenoreceptor agonist
0,060  0,009  Acetyl-CoA transferase 1 inhibitor
0,071  0,020  Lipocortins synthesis agonist
0,200  0,151  5 Hydroxytryptamine uptake stimulant
0,185  0,136  5 Hydroxytryptamine release stimulant
0,135  0,093  Acute respiratory distress syndrome (ARDS) treatment
0,176  0,134  Antidiabetic symptomatic
0,068  0,028  Postmenopausal disorders treatment
0,102  0,063  5-Lipoxygenase inhibitor
0,070  0,031  Androgen agonist
0,210  0,173  GST M1-1 substrate
0,133  0,096  Phospholipase A2 inhibitor
0,042  0,004  Retinoid X gamma receptor antagonist
0,141  0,104  Dual specificity phosphatase 3 inhibitor
0,046  0,009  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,049  0,013  Retinoid X receptor antagonist
0,069  0,035  Beta tubulin antagonist
0,164  0,130  VEGF expression inhibitor
0,129  0,095  Genotoxic
0,084  0,050  Topoisomerase II alpha inhibitor
0,147  0,113  Phospholipase C inhibitor
0,115  0,083  Acetylcholinesterase inhibitor
0,048  0,016  Glucocorticoid antagonist
0,036  0,005  Retinoic acid alpha receptor antagonist
0,127  0,097  Diuretic
0,046  0,018  Retinoic acid alpha receptor agonist
0,041  0,013  Retinoid X alpha receptor antagonist
0,032  0,005  Retinoic acid receptor antagonist
0,058  0,032  Alpha tubulin antagonist
0,034  0,009  Retinoid X gamma receptor agonist
0,089  0,065  SULT1E1 substrate
0,150  0,126  Antirickettsial
0,111  0,088  Cyclooxygenase 3 inhibitor
0,082  0,060  Estrogen-related receptor beta agonist
0,063  0,041  Antimycoplasmal
0,160  0,139  Antiviral (HIV)
0,164  0,143  Immunostimulant
0,172  0,151  Radioprotector
0,034  0,014  Liver X receptor alpha antagonist
0,031  0,011  Hedgehog signaling activator
0,037  0,019  HMG CoA reductase inhibitor
0,025  0,007  Retinoid X beta receptor antagonist
0,023  0,005  Thyroid hormone alpha agonist
0,178  0,162  Renal disease treatment
0,039  0,024  Glucose-6-phosphate dehydrogenase inhibitor
0,217  0,203  Antineoplastic (small cell lung cancer)
0,100  0,087  Topoisomerase II inhibitor
0,024  0,012  Retinoic acid gamma receptor agonist
0,033  0,021  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,017  0,005  Retinoic acid beta receptor antagonist
0,066  0,055  HIV-1 integrase inhibitor
0,034  0,023  Tubulin agonist
0,015  0,005  Retinoic acid receptor gamma antagonist
0,089  0,080  Nitric-oxide synthase inhibitor
0,092  0,084  Toll-Like receptor 4 antagonist
0,031  0,025  Estrogen receptor alpha agonist
0,022  0,016  Vitamin D receptor antagonist
0,072  0,066  Antitreponemal
0,057  0,051  Transcription factor AP-1 inhibitor
0,038  0,033  Liver X receptor alpha agonist
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,029  0,024  Liver X receptor antagonist
0,058  0,054  Hyperparathyroidism treatment
0,030  0,026  ATP citrate lysase inhibitor
0,022  0,019  Retinoic acid receptor agonist
0,014  0,012  Thyroid hormone alpha antagonist
0,094  0,093  Antitussive
0,043  0,042  Aldosterone antagonist
0,018  0,018  Retinoic acid beta receptor agonist

